0 Items - $0.00
Categories
A to Z

Alternative structural projections:

PET-cGMP

ß- Phenyl- 1, N²-ethenoguanosine- 3', 5'-cyclic monophosphate ( PET-cGMP ), sodium salt
Site-selective analogue of cyclic GMP
Cat. No.: P 001
    
CAS No.: [78080-27-0]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: P 001-10
Unit: 10 µmol / ~4.7 mg
$191.00
For other salt forms or metabolites please inquire. Potent membrane-permeant activator of both isozymes I α and I ß of cGMP-dependent protein kinase while only a poor stimulator of type II. Common agonists such as 8-Br-cGMP or 8-pCPT-cGMP mainly activate kinase subtypes I α and II. Detailed technical information and updated reference list available. References: Gamm et al., J. Biol. Chem., 270, 27380 - 27388 (1996), Vaandrager et al., J. Biol. Chem., 272, 11816 - 11823 (1997).
Cat. No. P 001
CAS number [78080-27-0]
Purity > 98% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₈H₁₅N₅O₇P · Na
Molecular weight [g/mol] 467.3
Modifications 1-cGMP, 2-cGMP
Target PKG (cGK) Activator
Lipophilicity 2.47
Absorption max [nm] 252
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 37400
  • 1. Brown R. L., Strassmaier T., Brady J. D.Karpen J. W., Curr. Pharmaceut. Design, 12, 3597 - 3613 (2006), "The Pharmacology of Cyclic Nucleotide-Gated Channels: Emerging from the Darkness"
  • 2. Haynes J. M.Cook A. L., Prostate, 66, 377 - 385 (2006), "Protein Kinase G-induced Activation of K-ATP Channels Reduces Contractility of Human Prostate Tissue"
  • 3. Lohmann S. M.Walter U., Frontiers Biosci., 10, 1313 - 1328 (2005), "Tracking Functions of cGMP-dependent Protein Kinase"
  • 4. Cook A. L. M.Haynes J. M., Cell. Signal., 16, 253 - 261 (2004), "Protein Kinase GII-mediated Proliferative Effects in Human Cultured Prostatic Stromal Cells"
  • 5. Genieser H.-G., Bos J. L., Christensen A. E., Doeskeland S. O., Havemann U., Manzau U., Rehmann H.Schwede F., Poster #THP016 Montreal, 12, 0 - 0 (2004), "Analogues of Cyclic AMP to Distinguish Between PKA and Epac"
  • 6. Christensen A. E.Doeskeland S. O., Handbook of Cell Signaling Academic Press/Elsevier Science San Diego CA, 2, 549 - 554 (2003), "Cyclic Nucleotide Analogs as Tools to Investigate Cyclic Nucleotide Signaling"
  • 7. Salowe S. P., Wiltsie J., Liberator P. A.Donald R. G. K., Biochemistry, 41, 4385 - 4391 (2002), "The Role of a Parasite-Specific Allosteric Site in the Distinctive Activation Behavior of Eimeria tenella cGMP-Dependent Protein Kinase"
  • 8. Cook A. L. M., Frydenberg M.Haynes J. M., Cell. Signal., 14, 1023 - 1029 (2002), "Protein Kinase G Activation of K-ATP Channels in Human-cultured Prostatic Stromal Cells"
  • 9. Truss M. C., Stief C. G., Jonas U., Ückert S., Becker A. J.Forssmann W.-G., Deutsche Offenlegungsschrift, 0, 0 - 0 (2001), "Verwendung von Substanzen, die den intrazellulären Gehalt von zyklischem Adenosinmonophosphat (cAMP) erhöhen oder die Aktivität cAMP-bindender Proteine stimulieren, zur Behandlung von Erkrankungen der Harnblase"
  • 10. Scott S.-P., Cummings J., Joe J. C.Tanaka J. C., Biophys. J., 78, 2321 - 2333 (2000), "Mutating Three Residues in the Bovine Rod Cyclic Nucleotide-Activated Channel Can Switch a Nucleotide from Inactive to Active"
  • 11. Muhonen W. W.Shabb J. B., Protein Sci., 9, 2446 - 2456 (2000), "Resonant Mirror Biosensor Analysis of Type I(Alpha) cAMP-dependent Protein Kinase B Domain-Cyclic Nucleotide Interactions"
  • 12. Francis S. H.Corbin J. D., Crit. Rev. Clin. Lab. Sci., 36, 275 - 328 (1999), "Cyclic Nucleotide-Dependent Protein Kinases: Intracellular Receptors for cAMP and cGMP Action"
  • 13. van der Zypp A.Majewski H., Clin. Exp. Pharmacol. Physiol., 25, 38 - 43 (1998), "Effect of cGMP Inhibitors on the Actions of Nitrodilators in Rat Aorta"
  • 14. Bradley K. K., Buxton I. L. O., Barber J. E., McGaw T.Bradley M. E., Amer. J. Physiol. -Cell Physiol., 44, 1668 - 1673 (1998), "Nitric Oxide Relaxes Human Myometrium by a cGMP-Independent Mechanism"
  • 15. Wyatt T. A., Naftilan A. J., Francis S. H.Corbin J. D., Am. J. Physiol., 274, 448 - 455 (1998), "ANF Elicits Phosphorylation of the cGMP Phosphodiesterase in Vascular Smooth Muscle Cells"
  • 16. Vaandrager A. B., Edixhoven M., Bot A. G. M., Kroos M. A., Jarchau T., Lohmann S. M., Genieser H.-G.De Jonge H. R., J. Biol. Chem., 272, 11816 - 11823 (1997), "Endogenous Type II cGMP-Dependent Protein Kinase Exists as a Dimer in Membranes and can be Functionally Distinguished from the Type I Isoforms"
  • 17. Gamm D. M., Francis S. H., Angelotti T. P., Corbin J. D.Uhler M. D., J. Biol. Chem., 270, 27380 - 27388 (1996), "The Type II Isoform of cGMP-dependent Protein Kinase is Dimeric and Possesses Regulatory and Catalytic Properties Distinct from the Type I Isoforms"
  • 18. Wei J. Y., Cohen E. D., Yan Y.-Y., Genieser H.-G.Barnstable C. J., Biochemistry, 35, 16815 - 16823 (1996), "Identification of Competitive Antagonists of the Rod Photoreceptor cGMP-Gated Cation Channel: Beta-Phenyl-1,N(2)-Etheno-Substituted cGMP Analogues as Probes of the cGMP-Binding Site"
  • 19. Hatton C. J.Peers C., Pflugers Arch.- Eur. J. Physiol., 433, 129 - 135 (1996), "Hypoxic Inhibition of K+ Currents in Isolated Rat Type I Carotid Body Cells - Evidence Against the Involvement of Cyclic Nucleotides"
  • 20. Wei J. Y., Cohen E. D., Yan Y.-Y., Genieser H.-G.Barnstable C. J., American Society for Neuroscience, 0, 880 - 0 (1996), "PET-substituted cGMP Analogs: Novel Antagonists of Rod Photoreceptor cGMP-gated Channel"
  • 21. Kuenzli K. A., Bradley M. E.Buxton I. L. O., Br. J. Pharmacol., 119, 737 - 743 (1996), "Cyclic GMP-independent Effects of Nitric Oxide on Guinea-pig Uterine Contractility"
  • 22. Ückert S., Truss M. C., Stief C. G., Becker A. J.Jonas U., Jahrbuch der Urologie, 0, 0 - 0 (1996), "Beeinflussung des Tonuszustandes Porciner Detrusormuskulatur durch Modulation Intrazellulärer Schlüsselenzyme in Vitro"
  • 23. Bayliss M. A., Pereira L., Games D. E., Brenton A. G., Harris F. M., Newton R. P.Walton T. J., Proc. 2. MS-Pharmaday Siena Italy #C 17-67 - 68, 0, 67 - 68 (1996), "Fast-Atom Bombardment Mass Spectrometry of Site-Specific Effectors of Cyclic Nucleotide Dependent Protein Kinases"
  • 24. Bäumner D.Nawrath H., Eur. J. Pharmacol., 273, 295 - 298 (1995), "Effects of Inhibitors of cGMP-dependent Protein Kinase in Atrial Heart and Aortic Smooth Muscle From Rats"
  • 25. Kwak B. R., Hermans M. M. P., De Jonge H. R., Lohmann S. M., Jongsma H. J.Chanson M., Mol. Biol. Cell, 6, 1707 - 1719 (1995), "Differential Regulation of Distinct Types of Gap Junction Channels by Similar Phosphorylating Conditions"
  • 26. Muresan S., Bologa C., Mracec M., Chiriac A., Jastorff B., Simon Z.Naray-Szabo G., J. Mol. Struct., 342, 161 - 171 (1995), "Comparative QSAR Study with Electronic and Steric Parameters for cAMP Derivatives with Large Substituents in Positions 2, 6 and 8"
  • 27. Muresan S., Bologa C., Chiriac A., Jastorff B., Kurunczi L.Simon Z., Quant. Struct.-Act. Relat., 13, 242 - 248 (1994), "Comparative Structure-Affinity Relations by MTD for Binding of Cycloadenosine Monophosphate Derivatives to Protein Kinase Receptors"
  • 28. Ouedraogo S., Stoclet J.-C.Bucher B., Br. J. Pharmacol., 112, 867 - 872 (1994), "Effects of cyclic GMP and Analogues on Neurogenic Transmission in the Rat Tail Artery"
  • 29. Francis S. H.Corbin J. D., Adv. Pharmacol., 26, 115 - 170 (1994), "Progress in Understanding the Mechanism and Function of Cyclic GMP-Dependent Protein Kinase"
  • 30. Schmidt H. H. H. W., Lohmann S. M.Walter U., Biochim. Biophys. Acta, 1178, 153 - 175 (1993), "The Nitric Oxide and cGMP Signal Transduction System: Regulation and Mechanism of Action"
  • 31. Sekhar K. R., Hatchett R. J., Shabb J. B., Wolfe L., Francis S. H., Wells J. W., Jastorff B., Butt E., Chakinala M. M.Corbin J. D., Mol. Pharmacol., 42, 103 - 108 (1992), "Relaxation of Pig Coronary Arteries By New and Potent cGMP Analogs That Selectively Activate Type I alpha Compared to Type I beta cGMP-Dependent Protein Kinase"
  • 32. Forte L. R., Thorne P. K., Eber S. L., Krause W. J., Freeman R. H., Francis S. H.Corbin J. D., Am. J. Physiol., 263, 607 - 615 (1992), "Stimulation of Intestinal Cl- Transport by Heat-stable Enterotoxin: Activation of cAMP-dependent Protein Kinase by cGMP"
  • 33. Shabb J. B., Buzzeo B. D., Ng L.Corbin J. D., J. Biol. Chem., 266, 24320 - 24326 (1991), "Mutating Protein Kinase cAMP-binding Sites into cGMP-binding Sites"
  • 34. Wolfe L., Corbin J. D.Francis S. H., J. Biol. Chem., 264, 7734 - 7741 (1989), "Characterization of a Novel Isozyme of cGMP-dependent Protein Kinase From Bovine Aorta"
  • 35. Weber I. T., Shabb J. B.Corbin J. D., Biochemistry, 28, 6122 - 6127 (1989), "Predicted Structures of the cGMP Binding Domains of the cGMP-Dependent Protein Kinase: A Key Alanine/Threonine Difference in Evolutionary Divergence of cAMP and cGMP Binding Sites"
  • 36. Francis S. H., Noblett B. D., Todd B. W., Wells J. N.Corbin J. D., Mol. Pharmacol., 34, 506 - 517 (1988), "Relaxation of Vascular and Tracheal Smooth Muscle by Cyclic Nucleotide Analogs That Preferentially Activate Purified cGMP-Dependent Protein Kinase"
  • 37. Corbin J. D., Oegreid D., Miller J. P., Suva R. H., Jastorff B.Doeskeland S. O., J. Biol. Chem., 261, 1208 - 1214 (1986), "Studies of cGMP Analog Specificity and Function of the Two Intrasubunit Binding Sites of cGMP-dependent Protein Kinase"
  • 38. Oegreid D., Doeskeland S. O.Miller J. P., J. Biol. Chem., 258, 1041 - 1049 (1983), "Evidence That Cyclic Nucleotides Activating Rabbit Muscle Protein Kinase I Interact with Both Types of cAMP Binding Sites Associated with the Enzyme"
  • 39. Miller J. P., Uno H., Christensen L. F., Robins R. K.Meyer R. B., Biochem. Pharmacol., 30, 509 - 515 (1981), "Effect of Modification of the 1-, 2-, and 6-Positions of 9-β-D-Ribofuranosylpurine Cyclic 3',5'- Phosphate on the Cyclic Nucleotide Specificity of Adenosine Cyclic 3',5'- Phosphate and Guanosine Cyclic 3',5'- Phosphate-dependent Protein Kinases"

Show more